Literature DB >> 5687588

The actions of caerulein on the smooth muscle of the gastrointestinal tract and the gall bladder.

G Bertaccini, G De Caro, R Endean, V Erspamer, M Impicciatore.   

Abstract

1. In the intact conscious dog, caerulein causes emesis and evacuation of the bowel. The mean effective dose by the intravenous route is 0.4-0.5 mug/kg, and by the subcutaneous route 3-4 mug/kg.2. The gall bladder in situ or as an isolated preparation is highly sensitive to caerulein. A few ng/kg injected intravenously are sufficient to stimulate the gall bladder in situ and less than 1 ng/kg per min is effective when infused intravenously. The isolated gall bladder is contracted by caerulein in concentrations as low as 0.03-2 ng/ml. Krebs solution. There is no tachyphylaxis but, generally, a good dose-response relationship. Hence the gall bladder, especially that of the guinea-pig, appears to be very suitable for the bioassay of caerulein and related peptides.3. In situ, the musculature of the gastrointestinal tract is also highly sensitive to caerulein. Doses as low as 1-5 ng/kg, administered intravenously, have a spasmogenic action on jejunal loops of the dog, and slightly larger doses contract the small intestine of the cat. The stomach and the large intestine seem to be somewhat less sensitive to the polypeptide. Caerulein has a considerable spasmogenic action on the rat pylorus but relaxes the sphincter of Oddi of the guinea-pig.4. Isolated preparations of the gastrointestinal tract are relatively insensitive to caerulein and tachyphylaxis occurs readily.5. Blockade with atropine produces different effects in different intestinal segments and in different animal species. The spasmogenic action of caerulein on the gall bladder is atropine-resistant.6. The effects of caerulein are similar to those of cholecystokinin-pancreozymin in the organs tested in situ or as isolated preparations. Caerulein, however, is always more potent than cholecystokinin-pancreozymin, even on a molar basis. Compared with caerulein, human gastrin I has negligible activity.7. The possible use of caerulein in cholecystography is discussed.

Entities:  

Mesh:

Substances:

Year:  1968        PMID: 5687588      PMCID: PMC1703344          DOI: 10.1111/j.1476-5381.1968.tb07052.x

Source DB:  PubMed          Journal:  Br J Pharmacol        ISSN: 0007-1188            Impact factor:   8.739


  11 in total

1.  On the biological assay of cholecystokinin and its dosage in cholecystography.

Authors:  E JORPES; V MUTT; L OLBE
Journal:  Acta Physiol Scand       Date:  1959-11-15

2.  The detection and estimation of bradykinin in the circulating blood.

Authors:  S H Ferreira; J R Vane
Journal:  Br J Pharmacol Chemother       Date:  1967-03

3.  Effects of gastrin and its analogues on isolated smooth muscles.

Authors:  E Mikos; J R Vane
Journal:  Nature       Date:  1967-04-01       Impact factor: 49.962

4.  The action of caerulein on the systemic arterial blood pressure of some experimental animals.

Authors:  G Bertaccini; G De Caro; R Endean; V Erspamer; M Impicciatore
Journal:  Br J Pharmacol Chemother       Date:  1968-05

5.  Effect of gastrin II on the motility of the gastrointestinal tract.

Authors:  A N Smith; D Hogg
Journal:  Lancet       Date:  1966-02-19       Impact factor: 79.321

6.  Effect of cholecystokinin on small intestine.

Authors:  P Hedner; H Persson; G Rorsman
Journal:  Acta Physiol Scand       Date:  1967-06

7.  Secretory response of the human pancreas to continuous intravenous infusion of pancreozymin-cholecystokinin (Cecekin).

Authors:  J G Banwell; B E Northam; W T Cooke
Journal:  Gut       Date:  1967-08       Impact factor: 23.059

8.  Isolation of aspartyl-phenylalanine amide from cholecystokinin-pancreozymin.

Authors:  V Mutt; J E Jorpes
Journal:  Biochem Biophys Res Commun       Date:  1967-02-21       Impact factor: 3.575

9.  The role of gastrin in gastroileocolic responses.

Authors:  A M Connell; C J Logan
Journal:  Am J Dig Dis       Date:  1967-03

10.  The actions of caerulein on gastric secretion of the dog and the rat.

Authors:  G Bertaccini; R Endean; V Erspamer; M Impicciatore
Journal:  Br J Pharmacol       Date:  1968-10       Impact factor: 8.739

View more
  34 in total

1.  Effect of selective and nonselective muscarinic blockade on cholecystokinin-induced gallbladder emptying in man.

Authors:  V Garrigues; J Ponce; C Cano; R Sopena; M Hoyos; A Del Val; J Berenguer
Journal:  Dig Dis Sci       Date:  1992-01       Impact factor: 3.199

2.  Action of caerulein, glucagon or prostaglandin E1 on the motility of intestinal villi.

Authors:  M Ihász; I Koiss; E P Németh; G Folly; M Papp
Journal:  Pflugers Arch       Date:  1976-08-24       Impact factor: 3.657

Review 3.  Biliary motility.

Authors:  P A Grace; G J Poston; R C Williamson
Journal:  Gut       Date:  1990-05       Impact factor: 23.059

4.  Controlled study of the effect of nicardipine and ceruletide on the sphincter of Oddi.

Authors:  G M Fullarton; S Falconer; A Campbell; W R Murray
Journal:  Gut       Date:  1992-04       Impact factor: 23.059

Review 5.  Cyclic AMP and gastric secretion.

Authors:  M S Amer
Journal:  Am J Dig Dis       Date:  1972-10

6.  Experiments on the mechanism of action of caerulein at the level of the guinea-pig ileum and colon.

Authors:  M Del Tacca; A Crema; G Soldani
Journal:  Agents Actions       Date:  1970-08

7.  The action of caerulein on gastro-intestinal propulsion in mice.

Authors:  D Piccinelli; F Ricciotti; A Catalani; P Sale
Journal:  Naunyn Schmiedebergs Arch Pharmacol       Date:  1973       Impact factor: 3.000

8.  Structure-activity relationship of some analogues of gastrin and cholecystokinin on intestinal smooth muscle of the guinea-pig.

Authors:  E S Vizi; G Bertaccini; M Impicciatore; P Mantovani; J Zséli; J Knoll
Journal:  Naunyn Schmiedebergs Arch Pharmacol       Date:  1974       Impact factor: 3.000

9.  The actions of caerulein on gastric secretion of the dog and the rat.

Authors:  G Bertaccini; R Endean; V Erspamer; M Impicciatore
Journal:  Br J Pharmacol       Date:  1968-10       Impact factor: 8.739

10.  Discrepancies between the doses of cholecystokinin or caerulein-stimulating exocrine and endocrine responses in perfused isolated rat pancreas.

Authors:  M Otsuki; C Sakamoto; H Yuu; M Maeda; S Morita; A Ohki; N Kobayashi; K Terashi; K Okano; S Baba
Journal:  J Clin Invest       Date:  1979-03       Impact factor: 14.808

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.